Detection and measurement of paracaspase malt1 activity

Methods in Molecular Biology

Volumn 1133, Issue , 2014, Pages 177-188

  Hailfinger, Stephan ^a   Pelzer, Christiane ^a   Thome, Margot ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Immunomodulation; Lymphocyte activation; Lymphoma; NF kB

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCOSA ASSOCIATED LYMPHOID TISSUE TRANSLOCATION PROTEIN 1; PARACASPASE; PROTEIN; PROTEINASE; UNCLASSIFIED DRUG; MALT1; PROTEIN BCL 10;

ARTICLE; DIMERIZATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; UBIQUITINATION; ENZYME ANALYSIS; ENZYME PURIFICATION; LYMPHOCYTE; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84958778236     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-357-3_11     Document Type: Article

References (34)

1. Du MQ (2011) MALT lymphoma: many roads lead to nuclear factor-kappaB activation. Histopathology 58(1):26-38
2. Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, Koonin EV, Dixit VM (2000) Identifi cation of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 6(4):961-967
3. Rosebeck S, Rehman AO, Lucas PC, McAllister-Lucas LM (2011) From MALT lymphoma to the CBM signalosome: three decades of discovery. Cell Cycle 10(15):2485-2496
4. Thome M, Charton JE, Pelzer C, Hailfi nger S (2010) Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol 2(9):a003004
5. Staudt LM (2010) Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol 2(6):a000109
6. Ruland J, Duncan GS, Wakeham A, Mak TW (2003) Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 19(5):749-758
7. Ruefl i-Brasse AA, French DM, Dixit VM (2003) Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase. Science 302(5650):1581-1584
8. Thome M (2008) Multifunctional roles for MALT1 in T-cell activation. Nat Rev Immunol 8:495-500
9. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2(10):725-734
10. Wiesmann C, Leder L, Blank J, Bernardi A, Melkko S, Decock A, D'Arcy A, Villard F, Erbel P, Hughes N, Freuler F, Nikolay R, Alves J, Bornancin F, Renatus M (2012) Structural determinants of MALT1 protease activity. J Mol Biol 419(1-2):4-21
11. Yu JW, Jeffrey PD, Ha JY, Yang X, Shi Y (2011) Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region. Proc Natl Acad Sci U S 108(52):21004-21009
12. Snipas SJ, Wildfang E, Nazif T, Christensen L, Boatright KM, Bogyo M, Stennicke HR, Salvesen GS (2004) Characteristics of the caspase- like catalytic domain of human paracaspase. Biol Chem 385(11):1093-1098
13. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ (2004) The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 14(3): 289-301
14. Oeckinghaus A, Wegener E, Welteke V, Ferch U, Arslan SC, Ruland J, Scheidereit C, Krappmann D (2007) Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. EMBO J 26(22):4634-4645
15. Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF, Yamaoka S, Seto M, Nunez G (2001) Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 276(22):19012-19019
16. Rebeaud F, Hailfi nger S, Posevitz-Fejfar A, Tapernoux M, Moser R, Rueda D, Gaide O, Guzzardi M, Iancu EM, Rufer N, Fasel N, Thome M (2008) The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat Immunol 9:272-281
17. Coornaert B, Baens M, Heyninck K, Bekaert T, Haegman M, Staal J, Sun L, Chen ZJ, Marynen P, Beyaert R (2008) T cell antigen receptor stimulation induces MALT1 paracaspasemediated cleavage of the NF-kappaB inhibitor A20. Nat Immunol 9(3):263-271
18. Vercammen D, Declercq W, Vandenabeele P, Van Breusegem F (2007) Are metacaspases caspases? J Cell Biol 179(3):375-380
19. Duwel M, Welteke V, Oeckinghaus A, Baens M, Kloo B, Ferch U, Darnay BG, Ruland J, Marynen P, Krappmann D (2009) A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J Immunol 182(12):7718-7728
20. Hailfi nger S, Nogai H, Pelzer C, Jaworski M, Cabalzar K, Charton JE, Guzzardi M, Decaillet C, Grau M, Dorken B, Lenz P, Lenz G, Thome M (2011) Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. Proc Natl Acad Sci U S A 108(35):14596-14601
21. Weih F, Durham SK, Barton DS, Sha WC, Baltimore D, Bravo R (1996) Both multiorgan infl ammation and myeloid hyperplasia in RelBdefi cient mice are T cell dependent. J Immunol 157(9):3974-3979
22. Marienfeld R, May MJ, Berberich I, Serfl ing E, Ghosh S, Neumann M (2003) RelB forms transcriptionally inactive complexes with RelA/p65. J Biol Chem 278(22):19852-19860
23. Mauro C, Pacifi co F, Lavorgna A, Mellone S, Iannetti A, Acquaviva R, Formisano S, Vito P, Leonardi A (2006) ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB. J Biol Chem 281(27): 18482-18488
24. Staal J, Driege Y, Bekaert T, Demeyer A, Muyllaert D, Van Damme P, Gevaert K, Beyaert R (2011) T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. EMBO J 30(9):1742-1752
25. Uehata T, Iwasaki H, Vandenbon A, Matsushita K, Hernandez-Cuellar E, Kuniyoshi K, Satoh T, Mino T, Suzuki Y, Standley DM, Tsujimura T, Rakugi H, Isaka Y, Takeuchi O, Akira S (2013) Malt1-induced cleavage of regnase-1 in CD4 helper T cells regulates immune activation. Cell 153(5):1036-1049
26. Rosebeck S, Madden L, Jin X, Gu S, Apel IJ, Appert A, Hamoudi RA, Noels H, Sagaert X, Van Loo P, Baens M, Du MQ, Lucas PC, McAllister-Lucas LM (2011) Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation. Science 331(6016):468-472
27. Hachmann J, Snipas SJ, van Raam BJ, Cancino EM, Houlihan EJ, Poreba M, Kasperkiewicz P, Drag M, Salvesen GS (2012) Mechanism and specifi city of the human paracaspase MALT1. Biochem J 443(1):287-295
28. Fontan L, Yang C, Kabaleeswaran V, Volpon L, Osborne MJ, Beltran E, Garcia M, Cerchietti L, Shaknovich R, Yang SN, Fang F, Gascoyne RD, Martinez-Climent JA, Glickman JF, Borden K, Wu H, Melnick A (2012) MALT1 small molecule inhibitors specifi cally suppress ABCDLBCL in vitro and in vivo. Cancer Cell22(6):812-824
29. Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM, Ricci JE, Edris WA, Sutherlin DP, Green DR, Salvesen GS (2003) A unifi ed model for apical caspase activation. Mol Cell 11(2):529-541
30. Roschitzki-Voser H, Schroeder T, Lenherr ED, Frolich F, Schweizer A, Donepudi M, Ganesan R, Mittl PR, Baici A, Grutter MG (2012) Human caspases in vitro: expression, purifi cation and kinetic characterization. Protein Expr Purif 84(2):236-246
31. Pelzer C, Cabalzar K, Wolf A, Gonzalez M, Lenz G, Thome M (2013) MALT1 protease activity is controlled by monoubiquitination. Nat Immunol 14:337-345
32. Hailfi nger S, Lenz G, Ngo V, Posvitz-Fejfar A, Rebeaud F, Guzzardi M, Penas EM, Dierlamm J, Chan WC, Staudt LM, Thome M (2009) Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A 106(47): 19946-19951
33. Ferch U, Kloo B, Gewies A, Pfander V, Duwel M, Peschel C, Krappmann D, Ruland J (2009) Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 206(11):2313-2320
34. Anderson NL, Anderson NG (1978) Analytical techniques for cell fractions. XXII. Twodimensional analysis of serum and tissue proteins: multiple gradient-slab gel electrophoresis. Anal Biochem 85(2):341-354